UK Scientists test common painkiller as potential treatment for Covid-19

Scientists in London are testing whether a common painkiller and anti-inflammatory medicine a form of Ibuprofen called flarin can help patients with Covid-19

Researchers from London’s Guy’s Hospital, St Thomas’ Hospital and King’s College are running a trial to see whether the painkiller and anti-inflammatory medicine Ibuprofen can be used to treat coronavirus patients

Richard Beale, a professor of intensive care medicine at the NHS trust, said, “As a new illness, there are limited treatment options for patients with Covid-19.The clinical trial will assess whether this unique formulation of an established drug benefits patients”

The trial which is called Liberate, was launched after studies conducted on animals suggested that the medication could treat acute respiratory distress syndrome

Trial aims to test flarin on 230 people who have been hospitalized due to Covid-19 and have acute respiratory failure. Also, only patients who are 18 or older are eligible.

The estimated date for initial results is Sept. 25, 2020, and the final estimated study completion date is May 25, 2021.